News of mega-mergers involving the likes of Pfizer and Wyeth or Merck and Schering Plough have turned the pharmaceutical industry on its ear. But what does this mean for you and your patients? John Kreger, a principal with the health care investment bank William Blair & Company, tells the Chicago Tribune's Bruce Japsen about how consolidation among drug companies could impact doctors and their patients.
advertisement
When Drug Companies Merge & the Effect on Your Practice
Share
Save
Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
News of mega-mergers involving the likes of Pfizer and Wyeth or Merck and Schering Plough have turned the pharmaceutical industry on its ear. But what does this mean for you and your patients? John Kreger, a principal with the health care investment bank William Blair & Company, tells the Chicago Tribune's Bruce Japsen about how consolidation among drug companies could impact doctors and their patients.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
advertisement
Recommended
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?